AIMOVIG
Active substance: erenumab
INJECTION, SOLUTION · ERENUMAB 140 mg/mL
United StatesActive
Marketing holder: Amgen, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ERENUMAB · 140 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-783f-7a36-ae73-70ccb0d8d04a,01a12093-c3d7-72be-89f9-e73e6ff6b55f,01a12093-c4ed-78b1-90a8-8370c772c667,01a12096-450e-73da-b759-f6376eabeb50;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-842
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 55513-842 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-842 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-842 · Verified 2026-10-09 · open in source